mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway

This publication has 63 references indexed in Scilit:

• Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer
  Journal of Medicinal Chemistry, 2010
• Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
  Published by Elsevier ,2010
• Termination of autophagy and reformation of lysosomes regulated by mTOR
  Nature, 2010
• Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
  Molecular Cell, 2010
• DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
  Cell, 2009
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
  Proceedings of the National Academy of Sciences, 2008
• SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
  Published by Elsevier ,2008
• LXRs regulate the balance between fat storage and oxidation
  Cell Metabolism, 2005
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
  Nature Cell Biology, 2004
• mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
  Cell, 2002